Lars Wilde, Founder of ATAI Life Sciences

Lars Wilde is the founder of ATAI Life Sciences. ATAI Life Sciences has raised $505M in total funding. Latest round: Series D. Based in Berlin, Germany.

About Lars Wilde

Lars Wilde is a co-founder of ATAI Life Sciences, a biopharmaceutical company based in Berlin, Germany. Founded in 2018, ATAI Life Sciences operates a decentralized platform focused on developing psychedelic and non-psychedelic therapeutics for severe mental health disorders. The company raised $225 million during its June 2021 NASDAQ IPO and has secured $505 million across 5 funding rounds.

Lars Wilde at a glance

More founders in Berlin, Germany (44)

Browse related founder lists (6)

Full founder directory · Investor directory · Company funding database · Fundraising library